FdaApplication
BLA 125370
Identifiers
- fda_app_no: BLA125370
Properties
| Property | Value |
|---|---|
| applicant_name | GlaxoSmithKline LLC |
| application_type | BLA |
| approval_date | 2011-03-09 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BENLYSTA | BELIMUMAB | 400MG | INJECTABLE;INJECTION |
| BENLYSTA | BELIMUMAB | 120MG | INJECTABLE;INJECTION |
2 products